Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $118.68 USD
Change Today +1.02 / 0.87%
Volume 5.5M
CELG On Other Exchanges
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Perry A. Karsen

Chief Executive Officer of Celgene Cellular Therapeutics, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 47 board members in 5 different organizations across 10 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Perry A. Karsen serves as the President of Stalar 4, Inc. and Stalar 3 Inc. Mr. Karsen serves as an Executive Officer of Healthcare IT, Inc. He serves as Chief Executive Officer of Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation. Mr. Karsen served as the Chief Operations Officer of Celgene Corporation since July 2010 until August 1, 2014, and its Executive Vice President since February 15, 2012 until August 1, 2014. He served as the ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: --

Board Members Memberships*

Former Director
Former Director
Former Director
President and Director
President and Director
Director, Member of Audit Committee and Member of Compensation, Nominating & Governance Committee


Master's Degree
Duke University
University of Illinois-Urbana-Champaign
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$645,833

Stock Options*

Restricted Stock Awards$1,008,796
All Other Compensation$31,129
Exercised Options93,008
Exercised Options Value$8,312,929
Exercisable Options32,922
Unexercisable Options129,512
Total Value of Options$8,312,929
Total Number of Options255,442

Total Compensation*

Total Annual Cash Compensation$3,841,968
Total Short Term Compensation$645,833
Other Long Term Compensation$1,039,925
Total Calculated Compensation$7,051,343
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $118.68 USD +1.02


Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at